1. Predictors and prevalence of COVID-19 vaccination in patients with focal epilepsy following resection surgery.
- Author
-
Yang, Yuyu, Lv, Jin, He, Chenmin, Shen, Chunhong, Xu, Sha, Guo, Yi, Ding, Yao, Zheng, Zhe, Zhu, Junming, Wang, Shuang, Ding, Meiping, and Wang, Shan
- Subjects
- *
SURGICAL excision , *COVID-19 , *PARTIAL epilepsy , *COVID-19 vaccines , *PEOPLE with epilepsy , *TEMPORAL lobectomy - Abstract
• Inactivated vaccines appear to be safe for PWE following resection surgery. • Individuals with active seizures may have a reduced acceptance of vaccines. • Education and public awareness campaigns focused on promoting vaccine safety in children are required to increase COVID-19 vaccination rates. In light of the ongoing COVID-19 pandemic, vaccination has emerged as the primary and most effective solution. The aim of this study was to examine compliance rates of vaccination and explore the factors that predict vaccine uptake among patients with epilepsy (PWE) who have undergone resection surgery. To examine the variations in vaccination coverage, safety concerns, and factors influencing vaccination hesitancy among PWE who have undergone resection surgery, this study recruited patients with at least one-year follow-up. We utilized questionnaires to gather clinical characteristics and obtain information regarding COVID-19 vaccines. Among the 303 patients included in the study, a majority of 229 (75.58%) achieved a seizure-free outcome (Engel Ia). Of these patients, 178 (58.75%) received at least one dose of COVID-19 vaccine, and the vaccination rate has remained relatively consistent over the past six months. Nearly 94.95% of those who received the vaccine completed the full vaccination regimen, with the majority (n = 174, 97.75%) opting for an inactivated vaccine. Only three patients reported side effects unrelated to epilepsy, and one patient experienced a worsening of typical aura seizures within one month after vaccination. Notably, significant positive associations were observed between COVID-19 vaccine acceptance and adulthood (age 18 years or older) (OR = 1.820, 95% CI = 1.018–3.252, p = 0.043) as well as achieving a seizure-free outcome (OR = 2.823, 95% CI = 1.619–4.921, p < 0.001). Regarding the unvaccinated patients, approximately one-fifth expressed willingness to receive a future COVID-19 vaccine, while the remainder were hesitant (41.60%) or unsure (39.20%) about vaccination. These reservations mainly stemmed from concerns about the potential worsening of seizures and vaccine safety. Inactivated vaccines can be considered safe for individuals with epilepsy who have undergone resection surgery. The likelihood of being vaccinated was found to be comparatively higher among the cohort with seizure-free status or adults. To promote COVID-19 vaccination among children, it is crucial to implement comprehensive education and public awareness campaigns that emphasize the safety of vaccines. These efforts will help encourage widespread acceptance of vaccination and ensure the well-being of individuals with epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF